Not Signed In -
Osteoporosis |
Bone Loss |
Clinical Trial: Davallia Divaricata BL
This study is currently recruiting patients.
Verified by National Taiwan University Hospital January 2002
|
Purpose
We has determined the therapeutic and toxic effects of the traditional herb on ovariectomized Wistar rat.
The Final years well determine its effects on the therapy of women who are iver 45 years old and postmenopausal with osteoporosis.
| Condition | Intervention | Phase |
|---|---|---|
| Osteoporosis | Drug: Gu-Sui-Bu | Phase I |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research
Expected Total Enrollment: 100
Study start: January 2002; Expected completion: January 2004
Last follow-up: January 2003; Data entry closure: January 2004
Eligibility
Inclusion Criteria:
- postmenopausal osteoporosis
Exclusion Criteria:
- Insulin dependent diabetes
Location and Contact Information
Taiwan, 7, Chung-Shan South Road
National Tiawan University Medical Center, Taipei, 7, Chung-Shan South Road, 100, Taiwan; Recruiting
Liu Hwa-Chang, Ph.D, Study Chair, National Taiwan University Medical Center
More Information
Last Updated: September 9, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00154609
Health Authority: Taiwan: Department of Health
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
